Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PEN-221 |
Synonyms | |
Therapy Description |
PEN-221 is a small peptide targeting Sstr2 in conjugation with DM1, which may target Sstr2-positive tumor cells for cytotoxicity (Proceedings of the AACR, Vol 58, Apr 2017, Abstract # 39, PMID: 31649014, PMID: 30735385). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PEN-221 | PEN221|PEN 221 | PEN-221 is a small peptide targeting Sstr2 in conjugation with DM1, which may target Sstr2-positive tumor cells for cytotoxicity (Proceedings of the AACR, Vol 58, Apr 2017, Abstract # 39, PMID: 31649014, PMID: 30735385). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02936323 | Phase Ib/II | PEN-221 | PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers | Completed | USA | GBR | 0 |